Business Segments China Isotope & Radiation Corporation
Stocks
1763
CNE1000031F4
Medical Equipment, Supplies & Distribution
|
Market Closed -
Hong Kong S.E.
01:38:09 02/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 13.28 HKD | +1.07% |
|
-2.35% | -34.26% |
| 23/09 | China Isotope & Radiation Unit's Lu-177 API Filing Clears US FDA Review | MT |
| 28/08 | China Isotope & Radiation Corporation Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Gross Profit: Breakdown by Business Segment
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Products | ||||||||||
Nuclear Medicines | 375.5Cr | 392.51Cr | 413.23Cr | 417.11Cr | 402.01Cr | |||||
Gross Profit | 269.66Cr | 282.31Cr | 289.29Cr | 291.98Cr | 282.04Cr | |||||
| - | - | - | - | 3L | ||||||
Medical Laboratory Services | ||||||||||
Other Businesses | - | - | 82Cr | 130.58Cr | 160.19Cr | |||||
Gross Profit | - | - | 8.46Cr | 14Cr | 14Cr | |||||
Independent Clinical Medical and Laboratory Services and Other Businesses (Excluding Radiation Therapy Equipments and Related Services) | 34Cr | 75Cr | - | - | - | |||||
Gross Profit | 14Cr | 27Cr | - | - | - | |||||
| - | - | - | - | 2.47Cr | ||||||
Independent Clinical Medical and Laboratory Services and Other Businesses | - | - | - | - | - | |||||
Gross Profit | - | - | - | - | - | |||||
Medical Consumables | ||||||||||
Radioactive Sources and Application | 55Cr | 62Cr | 64Cr | 75Cr | 84Cr | |||||
Gross Profit | 23Cr | 28Cr | 28Cr | 32Cr | 42Cr | |||||
| - | - | - | - | 3.1Cr | ||||||
Medical Testing, Analyzing, and Diagnostic Equipment | ||||||||||
Nuclear Medical Equipment and Related Services | 40Cr | 74Cr | 94Cr | 123.14Cr | 60Cr | |||||
Gross Profit | 13Cr | 14Cr | 17Cr | 22Cr | 16Cr | |||||
| - | - | - | - | 2L | ||||||
Healthcare Referral Services | ||||||||||
Irradiation Application | 14Cr | 16Cr | 18Cr | 20Cr | 19Cr | |||||
Gross Profit | 7.37Cr | 8.51Cr | 9.14Cr | 10Cr | 11Cr | |||||
| - | - | - | - | 66.45L | ||||||
Elimination of Inter-Segment | -5.24Cr | -5.65Cr | -7.11Cr | -7.97Cr | -6.28Cr | |||||
Gross Profit | -2.34Cr | -9.28Cr | -3.03Cr | -1.97Cr | -2.24Cr |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
People's Republic of China (PRC) | 514.37Cr | 614.62Cr | 663.5Cr | 757.48Cr | 718.77Cr | |||||
Total Assets | 1.05TCr | 1.17TCr | 1.32TCr | 1.48TCr | 1.57TCr | |||||
Interest Expense | -3.4Cr | -3.27Cr | -3.48Cr | -4.72Cr | -6.4Cr | |||||
Income Tax Expense | 13Cr | 17Cr | 15Cr | 17Cr | 34Cr | |||||
D&A | 19Cr | 21Cr | 26Cr | 24Cr | 25Cr | |||||
CAPEX | -43Cr | -53Cr | -90Cr | -103.22Cr | -57Cr | |||||
Gross Profit | 324.19Cr | 351.47Cr | 348.22Cr | 368.28Cr | 362.16Cr | |||||
Net Income | 34Cr | 39Cr | 37Cr | 41Cr | 33Cr | |||||
EBT | 80Cr | 92Cr | 92Cr | 104.52Cr | 100.41Cr | |||||
Operating Income | 78Cr | 91Cr | 94Cr | 108.64Cr | 105.86Cr |
Select your edition
All financial news and data tailored to specific country editions
